CLINICAL_TRIALS
trial_result
· 2011-05-10
Clinical Trial Update: Prevention of Contrast-Induced Nephropathy [NA]
Summary
This entry notes the completed clinical trial evaluating prevention of contrast-induced nephropathy sponsored by the University of Alberta.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Alberta | Conditions: Contrast-induced Nephropathy, Acute Renal Failure | NA | Status: COMPLETED